Santori & Peters Inc’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $309K | Buy |
2,408
+23
| +1% | +$2.69K | 0.09% | 68 |
|
|
2026
Q1 | $287K | Buy |
2,385
+38
| +2% | +$4.39K | 0.09% | 66 |
|
|
2025
Q4 | $247K | Buy |
+2,347
| New | +$220K | 0.08% | 65 |
|
|
2025
Q2 | – | Sell |
-2,512
| Closed | -$225K | – | 71 |
|
|
2025
Q1 | $225K | Sell |
2,512
-58
| -2% | -$5.42K | 0.09% | 59 |
|
|
2024
Q4 | $256K | Sell |
2,570
-320
| -11% | -$33K | 0.1% | 55 |
|
|
2024
Q3 | $328K | Sell |
2,890
-230
| -7% | -$27.3K | 0.13% | 50 |
|
|
2024
Q2 | $386K | Sell |
3,120
-380
| -11% | -$48.9K | 0.17% | 41 |
|
|
2024
Q1 | $462K | Buy |
3,500
+26
| +0.7% | +$3.21K | 0.2% | 35 |
|
|
2023
Q4 | $379K | Buy |
3,474
+52
| +2% | +$5.4K | 0.18% | 38 |
|
|
2023
Q3 | $352K | Sell |
3,422
-29
| -0.8% | -$3.13K | 0.19% | 40 |
|
|
2023
Q2 | $398K | Buy |
3,451
+11
| +0.3% | +$1.25K | 0.2% | 35 |
|
|
2023
Q1 | $366K | Buy |
3,440
+66
| +2% | +$7.13K | 0.2% | 36 |
|
|
2022
Q4 | $374K | Sell |
3,374
-33
| -1% | -$3.37K | 0.22% | 32 |
|
|
2022
Q3 | $293K | Sell |
3,407
-116
| -3% | -$10.4K | 0.2% | 34 |
|
|
2022
Q2 | $321K | Buy |
3,523
+275
| +8% | +$24.4K | 0.21% | 36 |
|
|
2022
Q1 | $266K | Buy |
+3,248
| New | +$256K | 0.15% | 41 |
|
|
2021
Q2 | – | Sell |
-2,743
| Closed | -$201K | – | 59 |
|
|
2021
Q1 | $201K | Sell |
2,743
-144
| -5% | -$10.6K | 0.12% | 54 |
|
|
2020
Q4 | $228K | Sell |
2,887
-110
| -4% | -$8.41K | 0.13% | 75 |
|
|
2020
Q3 | $237K | Buy |
2,997
+13
| +0.4% | +$1.02K | 0.16% | 66 |
|
|
2020
Q2 | $220K | Buy |
2,984
+12
| +0.4% | +$903 | 0.17% | 48 |
|
|
2020
Q1 | $218K | Buy |
2,972
+11
| +0.4% | +$865 | 0.19% | 63 |
|
|
2019
Q4 | $256K | Buy |
2,961
+11
| +0.4% | +$903 | 0.17% | 65 |
|
|
2019
Q3 | $236K | Buy |
2,950
+10
| +0.3% | +$801 | 0.17% | 67 |
|
|
2019
Q2 | $235K | Buy |
2,940
+12
| +0.4% | +$919 | 0.17% | 63 |
|
|
2019
Q1 | $232K | Buy |
2,928
+116
| +4% | +$8.68K | 0.19% | 43 |
|
|
2018
Q4 | $205K | Buy |
+2,812
| New | +$199K | 0.18% | 75 |
|
|
2018
Q1 | – | Sell |
-2,101
| Closed | -$110K | – | 357 |
|
|
2017
Q4 | $110K | Buy |
+2,101
| New | +$116K | 0.1% | 70 |
|
Other funds holding MRK
Santori & Peters Inc's MRK Position: Q2 2026 in Review
Santori & Peters Inc increased its Merck (MRK) stake by 0.96% in Q2 2026, buying an estimated $2.69K and bringing the position to 2,408 shares worth $309K. The position accounts for 0.09% of the portfolio, ranked #68.
Santori & Peters Inc first reported a position in MRK in Q4 2017 and has held it in 27 quarters since. The position peaked at $462K in Q1 2024. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Santori & Peters Inc held 2,408 shares of Merck worth $309K as of Q2 2026.
- Santori & Peters Inc bought 23 Merck shares in Q2 2026, an estimated $2.69K.
- Merck made up 0.09% of Santori & Peters Inc's portfolio in Q2 2026, its #68 holding.
- Santori & Peters Inc first reported a position in Merck in Q4 2017 and has held it in 27 quarters since.
- Santori & Peters Inc's Merck position peaked at $462K in Q1 2024.
- 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Santori & Peters Inc's 13F filing for Q2 2026, filed 24 Jul 2026.